Studies were done to determine whether the minimal model approach and the glucose clamp measure equivalent indices of insulin action. Euglycemic glucose clamps (glucose, G: 85 mg/dl) were performed at two rates of insulin (I) 
Introduction
A consensus has emerged that insulin resistance is an important component in the etiology of glucose intolerance in a variety of metabolic conditions, including obesity (1), aging (2) , and noninsulin-dependent diabetes mellitus (3) . Thus, it is an important goal to be able to quantify the degree of sensitivity ofthe tissues to insulin as an indication of the prevalence and/or progress of metabolic disease, and to evaluate the effectiveness of specific therapies. In recent years, a variety ofapproaches have been put forth to yield either qualitative (4) or quantitative indices of in vivo insulin sensitivity (5) . Most recently, the euglycemic clamp of Andres and his colleagues has gained widespread use (6) .
While the glucose clamp is widely regarded as the "gold standard" for sensitivity measurement, it remains primarily a laboratory procedure, because it requires sophisticated equipment, highly trained personnel, and it is costly and labor inten-sive. There remains a need for alternative methods for measuring insulin sensitivity which require less experimental sophistication.
The minimal model methodology has been proposed as a simple alternative to the glucose clamp. With this method, the computer is used to calculate insulin sensitivity from the glucose and insulin dynamics observed during the frequently sampled intravenous glucose tolerance test (FSIGT1; [7] [8] [9] .
The question has arisen as to the accuracy of the insulin sensitivity index, SI, which is estimated from minimal model analysis ofthe FSIGT. Donner and his colleagues (10) , and Foley et al. (1 1) reported a weak, marginally significant correlation between insulin sensitivity determined by the minimal model approach and the euglycemic clamp, although the reason for this lack of correlation was not determined. Beard and his colleagues demonstrated that the correlation between these methods became much stronger (r = 0.83) when they utilized a modified FSIGT protocol, which entailed the sequential injection of glucose and tolbutamide (12) .
The results ofBeard and his colleagues suggest that the minimal model approach is an alternative to the euglycemic clamp, in that acceptable estimates ofinsulin sensitivity may be obtained from either. However, the attractiveness of the minimal model approach would increase if the sensitivity index derived therein were not just related to the clamp-based index, but if, in fact these independently derived measures were equivalent.
In the present study, we measured the insulin sensitivity index in a group of individuals of varying body weight, using both the euglycemic clamp, and the minimal model method. Our goal was to determine whether the model-based sensitivity index was simply a correlate of insulin sensitivity, or whether application of the minimal model yielded the same measure of insulin sensitivity as the euglycemic clamp method.
Methods
Subjects 10 subjects were studied (Table I; 9 male, 1 female). Body mass indices varied from 21 to 41 kg/m2. Thus, 4 subjects were of normal weight, and the remainder were obese. After admission to the Special Diagnosis and Treatment Unit at the San Diego Veterans Administration Hospital, subjects were put on a weight-maintaining diet (32 kCal/kg per d) with the following composition: carbohydrate 45%, protein 15%, fat 40%, served in three portions: I/5 at 8 a.m., %15 each at noon and 5 p.m. Each study was performed at least 48 h after admission, beginning at 7 a.m., after an overnight fast. All 10 patients were subjected to one euglycemic clamp study (insulin infusion rate 40 mU/min per m2) and an additional 1. Abbreviations used in this paper: BMI, body mass index; FSIGT, frequently sampled intravenous glucose tolerance test; GINF, glucose infusion; HGO, hepatic glucose output; Rd, glucose uptake; SA, surface area; SI, insulin sensitivity index; SIP(CISIp), clamp-derived insulin sensitivity index; VD, distribution volume. 
Glucose clamp studies
Euglycemic glucose clamp studies were conducted as previously described (13). Intracatheters were placed in one antecubital vein and a dorsal hand vein cannulated in the retrograde direction. The hand was kept in a heating pad to provide arterialized venous blood. Labeled glucose (3- [3H]glucose) was injected (60 tCi) and infused (0.6 ,Ci/min) thereafter for the entire experiment. 60 min after tracer infusion was begun, insulin was infused, continuing for 3 h. During the insulin infusion, glucose was maintained at 85 mg/dl by a variable infusion of 20% dextrose. The infusion was adjusted according to glucose determinations made every S min on a glucose analyzer (Yellow Springs Instruments, Yellow Springs, OH). For calculation of insulin sensitivity, we defined glucose infusion rate as steady state by calculating the average rate over the final 40 min of insulin infusion. Additional blood samples for determination of insulin and glucose specific activity were collected every 20 min during the glucose clamp.
FSIGT After placement of the two intracatheters, four basal samples were collected over 20 min, after which glucose (0.3 g/kg) was injected over 1 min, as described (9) . An additional injection of tolbutamide (Orinase i.v., Upjohn, Kalamazoo, MI) was given over 20 s, 20 min after glucose.
Subjects with body mass index (BMI) < 30 kg/in2 were given 300 mg tolbutamide; subjects with BMI > 30 kg/M2 were given 500 mg. These doses were equivalent to 4.19±0.40 mg/kg (SD) for the lower BMI subjects, and 4.52±0.80 mg/kg for the greater BMI subjects (P > 0.40). Blood samples (4 ml) were collected at the following times after glucose injection at t = 0: 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 24, 25, 27, 30, 40, 50, 60, 70, 90 , 100, 120, 140, 160, and 180 min. Addition of the tolbutamide injection to the glucose injection protocol decreases the coefficient of variation of the estimate of the insulin sensitivity index (SI) from 32 to 13% (reference 14, assuming a 2% coefficient of variation in the glucose assay).
Analytical methods
Glucose kinetics. Specific activity and glucose data were smoothed using the optimal segments method (15), and glucose appearance and disappearance rates were calculated from the derivative form of the Steele relationship (16 We have previously defined the insulin sensitivity index for the euglycemic glucose clamp, Sip(clamp), as the steady state ratio of the increment in glucose uptake (ARd) to the increment in plasma insulin concentration (Al), normalized to the ambient plasma glucose concentration (G) at which the clamp is performed (5) : SIP(clamp) = ARd/(AI X G).
In the present studies, we obtained values of plasma insulin and Rd at basal, as well as during the low and moderate dose insulin infusions (Table II) In view of the similarities of SIP(ctemP) values calculated for normal subjects regardless ofthe insulin interval used, we chose to utilize the 0 to 40 mU/min per m2 data for calculation of Sxpclamp) since it could also be used for the obese subjects, and it was very similar to the value obtained using best-fit linear regression (Table III) .
Mean SIP(CIamp) for all subjects was 1.87 X 10-2 dl/min per In2) per MU/ml (Table II) Thus, in this group of subjects differences in ag the conclusion that as much as 95% of the vari sensitivity ofthis group can be accounted for by t alone. Also, the data in Fig. 1 suggest that the sensitivity upon adiposity is linear and continua decreasing abruptly as adiposity exceeds a "thre:
In addition to the strong correlation with bod3 was somewhat more weakly (but significantly) related with basal insulin concentration (r = -0 FSIGT results. All subjects had a significant sulin response (Fig. 2 , integrated insulin over bN after glucose injection) which averaged 0.84±1 X min, and which was independent ofadiposity ( IV, NS) Tolbutamide, injected at 20 min, induc ondary peak in plasma insulin (Fig. 2) . The inteE min above basal response after tolbutamide was 4. by the distribution volume of glucose (SI X VD, see Appendix).
The minimal model assumes a single extracellular compartment of glucose distribution, and the volume of this compartment (VD) is equal to the ratio of the glucose dose to the increment in plasma glucose. This increment is the difference between the post-injection glucose concentration and the basal glucose: VD = Glucose dose/(Go -Gb).
The postinjection glucose concentration (Go) is found when the glucose data is fitted to the minimal model. The glucose data for the initial 8 min is not fitted by the model because during this interval glucose is mixing in the extracellular fluid (c.f., Fig.  2 ). When early mixing is ignored, the intercept of the modelpredicted time course of plasma glucose with the ordinate is the predicted glucose concentration that would have been observed if glucose had mixed instantaneously in the 1-compartment "glucose space." This value is Go. The values of VD for the 10 subjects are calculated in Table  V . The volumes ranged between 95.6 and 222 dl in the 10 subjects, averaging 16.1% of body wt. This fraction is considerably less than the entire extracellular glucose space, which has previously been estimated to be 26% of body wt (21) . In fact, the apparent glucose distribution volume was equal to 0.62 multiplied by the estimated total glucose distribution volume. During the euglycemic clamp, the exogenous glucose infusion
The relationship between SI and Sip(clamp) expressed in iden-must compensate for both the decrease in endogenous glucose tical units is shown in Fig. 5 . Again, the intercept is not different production and the increase in glucose uptake. Therefore, the from 0.00 (P > 0.40). The slope of the relationship between rate of glucose infusion is an indication of the total effect of the these indices of insulin sensitivity was 1.05±0.19 (SE). This slope infused insulin on glucose economy. Thus, we recalculated inis indistinguishable from 1.00 (P > 0.7). Thus, for the group as sulin sensitivity from clamp data using glucose infusion (GINF) a whole, these two measures of insulin sensitivity, SI and SmPfc]p) in place ofRd for the basal to 40 mU/M2 per min clamp studies.
apparently satisfied the criterion for equivalence discussed above. The sensitivity index parameter based on infusion is SI(clamp), Careful examination of Table VI reveals, however, that on defined as (AGINF/(AI * G)). This latter parameter (XSA) ava subject by subject basis there was a modest but significant eraged 0.052±0.007 dl/min per uU/ml for the 10 subjects, slightly tendency for SIX VD to exceed SmPfcIamp) surface area (SA) (P exceeding the model-based value of0.046±0.008 (Fig. 6 ). Thus, < 0.05 paired t test). One possible cause of this tendency for a the subtle decrement in the insulin sensitivity measure seen when greater sensitivity parameter with the model approach is a difRd was used was more than compensated for when total glucose infusion rate was substituted in the clamp-based index ofinsulin sensitivity. This result is consistent with the notion that the small decrease in SIP(cIamp) SA compared to SI* VD was due to the lack of inclusion of liver glucose production inherent in the R4-based, clamp-derived sensitivity index S1p(clamp).
The substitution of GINF for Rd did not change the equivalent relationship between the clamp based and model-based sensitivity indices. Slope ofthe relationship between Sl(ckmp) and SI was 0.93 (not different from 1.00, P > 0.5); the intercept was -0.003 (not different from 0.00, P > 0.5, data not shown).
Discussion
Insulin resistance is an important factor underlying the glucose intolerance observed in a variety ofmetabolic disorders. Among these conditions are some of major epidemiologic importance, such as aging, obesity, and NIDDM, as well as several less prevalent diseases (22) (23) (24) . Given the benefits that accrue from a better understanding ofthese conditions, it follows that it is important to develop approaches to assess insulin sensitivity which entail minimum risk and difficulty, but which provide maximum quantitative information. The availability of such approaches has the potential for improved classification of metabolic illness, better prognosis, and earlier detection and intervention.
The euglycemic clamp technique, conceived by Andres et al. (6) and widely exploited by others (c.f. reference 5) remains the most direct approach to assessment of whole-body insulin sensitivity. Using the clamp one may determine a direct doseresponse relationship between the steady state concentration of insulin in plasma and the effect ofinsulin to suppress endogenous glucose production and enhance glucose uptake. However, as we and others have discussed elsewhere, even these data can be difficult to interpret if comparisons are made among glucose clamp results obtained at different plasma glucose and/or insulin levels (25).
The above considerations have encouraged us to examine alternative approaches to measuring insulin sensitivity. In particular, we have been searching for a method which circumvents some of the aspects of the clamp which have prevented its use outside the clinical research laboratory. The criteria we have attempted to fulfill include the following: (a) no special equipment requirements for the performance of the test, (b) a test that may be performed in an office rather than a laboratory setting (such a test could be used for field studies), (c) reduced labor requirements, and (d) minimization of risk. In addition, and possibly more important, we have desired a methodology for which (e) the attainment of steady state is not a necessity. Finally, it was hoped that the test would provide an accurate assessment of insulin sensitivity which was (within limits) independent of glycemia and insulinemia.
To strive to satisfy these aforementioned criteria we have made use of the digital computer to analyze the dynamics of plasma insulin and glucose observed following glucose injection. The injection of glucose is simple to perform, and virtually risk free. By implementation of the "minimal model" of insulindependent net glucose disappearance on the computer (5, 7-9), we have been able to describe the effect of changes in plasma insulin on the postinjection decline of plasma glucose. From the model parameters which emerge from the fitting procedure, we can calculate the SI. This sensitivity parameter is a measure of the effect of an increment in plasma insulin to enhance the fractional net disappearance of glucose from an assumed single compartment of extracellular glucose distribution. There is evidence that within the physiological range this parameter is relatively independent ofthe levels of glycemia and insulinemia at which it is determined (12, 26) .
The potential of the minimal model approach seemed to us to satisfy most of the requirements we had set down. However, Donner et al. recently reported a very weak correlation (r = 0.44) between insulin sensitivity from the minimal model analysis, and that observed on a group of subjects using the euglycemic clamp (10, 1 1) . Given the demonstrated utility of the clamp, the Donner et al. reports seemed to demonstrate that the minimal model approach violated the accuracy criterion. If SI were indeed an inaccurate index, such a result would severely limit the usefulness of the minimal model approach.
Recent results reported by Beard and his colleagues, in collaboration with some of us (12) , have led to a potential explanation for the somewhat disappointing results of Donner et al. We showed that the correlation between the minimal model method and the euglycemic clamp could be considerably strengthened (r = 0.83) ifthe data used as a basis for calculating SI were obtained not from a glucose injection alone, but from a "modified" FSIGT protocol in which tolbutamide was also injected 20 min after glucose. This modified protocol produced a significantly greater plasma insulin response than glucose alone, and a substantial portion of the insulin response occurred after the 0-8 min postglucose injection mixing period (27) The present results confirm a strong and highly significant correlation between the insulin sensitivity index measured by the two methods. In fact, in the present studies there was a tendency for the correlation to be higher than was previously found (r = 0.89 compared with 0.83); presumably this may be explained by the fact that in the present studies we used subjects of widely varying body mass index, and are thus able to compare SI and SIp(clamp) in obesity, while Beard used only normal-weight subjects.
The increased variability of adiposity resulted in a wider range of SI in the present studies (0.66 to 7.34 X 10-4 min' per gU/ ml, an 11-fold difference). Assuming that a wider range in insulin sensitivity would be obtained with a greater variability of adiposity, a stronger correlation would be expected, based upon statistical principles (19) .
Of particular interest was the negative relationship between insulin sensitivity and obesity in these studies as BMI increased above the normal range (Figs. 1 and 3) . While we have insufficient data to determine whether adiposity will lead to relative insulin resistance within the normal limits of body mass index, apparently even mild obesity can have a measurable effect and possibly lead to the negative risk factors associated with diminished sensitivity to the hormone. Further, even after moderate obesity occurs, progression to more severe obesity leads to an additional, measurable decline in insulin action.
More significant than the strong correlation between SIp(cialnp) and SI in the present studies are the following facts: first, that the correlation passed through the origin (0, 0); second, that when properly corrected for differences in units, the slope ofthe relationship was close to unity. In addition, when glucose infusion rate was used as a basis for calculating clamp-based sensitivity, mean values of sensitivity were very similar with both methods (0.046 versus 0.052 dl/min per uU/ml). These results provide strong evidence that the minimal model method and the euglycemic clamp are measuring the same physiological parameter, rather than reflecting different processes which happen to be related to each other. In addition, these results imply that there is no important factor, unrelated to insulin sensitivity, which systematically biases the measurement of either SI or Si(clamp). Stated in more general terms, these results demonstrated that (except for random error due to measurement and biological variation between successive measurements) SI = SllmcLwp), providing that both parameters are expressed in identical units.
It should be emphasized that for a correlation analysis to be valid, the parameters correlated with each other must be assessed completely independently, i.e., there must not be any common measured variable that contributes to the value of both parameters being correlated. This criterion applies to the variables correlated in Fig. 4 as well as in Fig. 5 . Thus, SI and SIP(cdamp) were determined on the same individual, but on different days using entirely independent methods. The independence criterion also applies to the unit-corrected variables correlated in Fig. 3 (SI VD versus SMLpcp) -SA); no factor is common to both measurements.
Parameters SI and VD are both calculated from the FSIGT alone; SIPFclamp) is determined from the clamp alone, while surface area is estimated from height and weight (28) . If this important consideration of the independence of correlated parameters is not obeyed, the correlation coefficient between the different measures of insulin sensitivity could not be taken per se as evidence of equivalence of the two measures.
In the previous study of Beard et al. the regression line did not pass through the origin. A possible reason for the non-zero positive intercept in the earlier study was that sequential euglycemic clamps were performed on a single day, at two levels of insulin infusion. In contrast, in the present experiments the clamps were done at different rates of insulin infusion, on different days. Because the effect of insulin on glucose disposal is long lasting (29) , in sequential infusion studies there may be a "memory effect," such that a previous insulin infusion could augment the glucose uptake during a following infusion. Insulin infusion at a low rate followed by a higher one could act to increase ARd and therefore the value of SI(clamp) relative to SI, and this effect would be progressively more significant at higher insulin infusion rates. This putative memory effect might explain the apparent insulin-dependent bias of SJ(clamp) in the previous study.
One ofthe primary simplifications implemented in the model is that during the FSIGT, glucose distribution can be described by a single compartment representation, despite evidence for three-compartment distribution oflabeled glucose moieties when sufficient time is allotted (30, 31) . Apparently, since glucose is rapidly normalized during the FSIGT (as compared, for example, to the glucose clamp) little filling of the slow compartments takes place. That equivalent one-compartment representation is adequate to account for FSIGT dynamics is supported by our previous demonstration of single-exponential restitution of the blood glucose, following glucose injection, when the increase in insulin was prevented by somatostatin (32) . Thus, during the FSIGT, the glucose distribution system can be represented by an equivalent one-compartment model, with a single distribution volume, VD. Whereas it remains unknown what tissues in the body account for this equivalent single compartment, it remains, as Steele pointed out many years ago (33), a useful conceptual framework for describing glucose dynamics when a relatively short time frame is available for glucose distribution.
Particularly interesting in this regard are the calculated values for VD (Table V) which were estimated by fitting the minimal model. This apparent volume of distribution, calculated from the increment in plasma glucose (corrected for extracellular mixing), averaged 16.1% of the body wt. This value represents 0.62 times the total glucose distribution space, prevously estimated to equal 26% of the body wt (21) . What is interesting about the 0.62 factor is that it is almost equal to the so-called "pool fraction" Steele and his colleagues proposed many years ago (16, 21, 32) . Those investigators proposed that one could calculate the rate of glucose production during the non-steady state by assuming a single-compartment distribution volume equal to 65% of the total distribution volume, when insufficient time was available for glucose equilibration into the entire threecompartment extracellular volume. Their conclusion was validated in the dog under limited conditions by Radziuk and Vranic (34) .
The striking equivalence of the apparent distribution volume of the minimal model to the previously validated pool fraction suggests that for the short time periods and limited glucose loads, the single-compartment assumption with the pool fraction sim-plification is adequate to represent glucose kinetics. In addition, prediction of the previously validated one-compartment volume can be considered an independent validation of the minimal model. The ability of the modeling process to yield a measure of the single compartment equivalent glucose VD in individual subjects (Table V) raises the possibility that VD itself, estimated from the minimal model fit, could be used in the Steele relation, rather than the "population" value of 0.65 X 26% body wt, as is usually done (34) . Independent studies will have to be done to determine ifusing individualized estimates ofthe pool fraction from the minimal model provides a more accurate assessment ofglucose turnover rates from the Steele relationship than using the assumed pool fraction, 0.65.
Ofcourse, we observed some variation in the relation between SI and SIP(cwmp) (i.e., individual points did not lie exactly on the line of equality). What cannot be determined from the present study are the factors that contribute to this variability: how much is due to day-to-day variation in insulin sensitivity itself, how much to imprecision in the clamp measurement, and how much to imprecision in the minimal model analysis. The fact that the correlation was not improved markedly by substituting glucose infusion for R& in the calculation of clamp-based sensitivity indicates that the variance was not due to failure to include liver inhibition in SIP(camp). Actual reproducibility determinations will require future studies of repetitive measures of sensitivity in the same individuals, using the two methods. Despite the overall equivalence between sensitivity from the clamp and the model, we did find, on a paired basis, a marginally significant tendency for the sensitivity to be higher with the FSIGT than with the clamps, when the values were normalized to identical units (Table VI, Fig. 6 ). A possible explanation for this is that there is a difference between the definitions ofinsulin sensitivity using the clamps, versus minimal model-analyzed FSIGT data. With clamps, we defined sensitivity in terms ofthe action of insulin to augment glucose utilization (Rd). In the FSIGT, however, model-derived sensitivity is defined in terms ofthe ability of insulin to both augment glucose utilization and to inhibit hepatic glucose output. Thus, it is the total effect of insulin on the net glucose economy of the body which is represented in Si. Therefore, it would not be surprising if, on a subject-by-subject basis, the higher sensitivity found from the FSIGT compared to the glucose clamps may have been due to the inclusion of the liver effect in the definition of insulin sensitivity.
The hypothetical role ofinhibition ofhepatic glucose output (HGO) to the higher sensitivity measured by FSIGT compared to SIp~clamp) is diagramed in Fig. 7 . The average increment in sensitivity of FSIGT measurement over the Rd based measurement was 0.009 dl/min per uU per ml (Table VI) , and this increment was approximately the same for normal and obese subjects (Fig. 7) .
The hypothesis that the increment in the model-based compared to the Rd-based sensitivity is due to inclusion of HGO inhibition in the former, leads to two predictions.
First, the increment of the FSIGT-based over the Rd-based sensitivity can be accounted for by some fraction of the basal rate of HGO, because insulin can do no more than completely inhibit HGO regardless of the concentration achieved during the FSIGT. The increment in the model-based compared to the Rd-based sensitivity can be expressed in terms comparable with only [SIpz,,dp) = ARd/(AI G)]. SI is from the minimal model (p3/ P2, see Methods), while Sl(Cp) is calculated from clamp data using glucose infusion data only [SI(dp) = AGINF/(AI-G)]. GINF is the increment in glucose infusion at steady-state, and it is equal to (ARd -AHGO). Assuming that the inhibition of HGO is responsible for the larger estimate of insulin sensitivity when the FSIGT is used, compared to Rd-based glucose clamps, we can reach certain conclusions regarding the contribution of the insulin-mediated inhibition of HGO, compared to insulin stimulation of glucose uptake. First, in normal individuals only about 17% of SI is due to insulin inhibition of HGO; the remainder is due to insulin increasing Rd (Fig. 7) . Therefore, in such individuals it will matter little whether the liver effect is included in the overall sensitivity determination. Second, the contribution of HGO inhibition to sensitivity was similar in obese individuals and normals (0.008 versus 0.009 dl/min perguU/ml). Therefore, it would make little difference for comparing insulin sensitivity between normal and obese individuals whether the FSIGT or the Rd-based glucose clamp was used. In fact, the absolute difference in sensitivities would be virtually the same (FSIGT: 0.062-0.029 = 0.033 dl/ min per uU/ml; Rd-based clamp values: 0.053-0.021 = 0.032 dl/min per MU/ml). Therefore, it appears to be justified to use the parameter SI for assessing insulin action in individuals of differing sensitivity to the hormone, even though SI includes within it the effects of insulin to inhibit endogenous glucose production and to augment glucose utilization.
While the present data is consistent with the idea that the slightly higher index calculated from the FSIGT is due to liver suppression, it is still possible that there is an alternative reason. One possibility is that steady state glucose utilization was not achieved in our clamp experiments, despite 180 min of insulin infusion. This artifact could result in an underestimate of SIP(clamp). Other possibilities include unaccounted for loss of glucose via renal excretion which would lead to overestimation of VD. The latter possibility seems unlikely since < 3% of injected glucose is cleared during an intravenous glucose tolerance test (35, 36) , and renal clearance would contribute not to SI, but the term independent of the insulin response, SG (32) . However, whether our supposition is correct that the small differential is due to inclusion of liver suppression in SI, but not SIP(clamp), or whether the differential is due to some other cause remains to be tested experimentally.
In conclusion, the present data demonstrate that minimal model analysis of the frequently sampled intravenous glucose tolerance test yields a measure of insulin sensitivity which is equivalent to the same parameter measured by the euglycemic glucose clamp. The results imply that the measure is dominated by extrahepatic effects ofthe hormone. Previous poor correlation between these methods was apparently due to suboptimal dynamic testing protocols, rather than inadequacy of the minimal model itself. In addition, the FSIGT is less labor intensive and requires less specialized equipment than the glucose clamp, and the FSIGT yields some information about B-cell function (8) . Therefore, the present results indicate that the minimal model method is potentially useful for measuring insulin sensitivity in longitudinal or cross-sectional epidemiologic studies of insulin resistance in nondiabetic individuals, when use of the glucose clamp is not feasible for economic or practical reasons. Ofcourse, it will be necessary to extend validation studies to a wider variety of conditions and to larger populations if general use of the methodology is to be recommended.
Appendix
While they both reflect insulin sensitivity, SI and SIPclamp) are not directly comparable because they are expressed in different units (SI in min-' per AU/ml and SIPfclamp) in dl/(min per M2) per AU/ml). To convert them to a common unit it is necessary to use conversion factors which emerge from the method used to estimate them: SI should be converted using parameters estimated for the minimal model approach; SIP(clamp) conversion must use factors associated with the euglycemic glucose clamp.
The fundamental difference between SI and SIpn(camp) as used in the present work is that the former expresses the effect of insulin to increase net fractional disappearance of glucose from the extracellular "glucose space" (i.e., rate of net glucose disappearance divided by amount of glucose in the pool).2 The latter represents the effect of insulin to enhance glucose clearance (rate ofglucose uptake divided by plasma glucose concentration) per unit body surface area. Thus, these two parameters are normalized to different measures ofbody "size"; the former to the volume of distribution of glucose of the minimal model itself, the latter to body surface area. However, both parameters can be easily converted to a common index of insulin sensitivity: the effect of a unitary change in insulin to cause a given increment in glucose clearance.3 For purposes ofdiscussion, let us define the parameter Sc, which represents the insulin sensitivity index in units of increment in glucose clearance per unit increment in plasma insulin, expressed in units of deciliters per minute per microunit per milliliter.
Glucose clamp. To reiterate, SIpFc.amp) is defined as (A Rd/(AI X G)),
where Rd is expressed in mg/min per unit surface area of the body, I is in MU/ml, and G is in mg/dl. The units of SIP(clamp) are dl/(min per M2) per AU/ml, or clearance per unit surface area divided by insulin concentration. To convert SIP(clamp) to Sc, we simply multiply by the surface area of the individual expressed in M2. Then, for the euglycemic clamp, S, will be expressed in dl/min per AU/ml: Sc = Sip(clamp) x surface area.
(Al)
Minimal model. The fractional disappearance rate as used in SI is the net glucose disappearance rate divided by the glucose "pool" size, where the pool size is the mass of glucose in the single glucose compartment of the minimal model itself. Thus, if we define VD as the assumed single compartment distribution space with glucose concentration G, the net disappearance rate is given as the fractional rate multiplied by VD-G. However, to convert the net rate to glucose clearance it has to be divided by G. Thus, G drops out, and to convert SI to Sc we simply 2. "Net" glucose disappearance refers to the sum of any decrease in glucose production plus increase in glucose uptake, either of which will act to lower the plasma glucose concentration. 3. Actually, for SI this is given in terms of net glucose clearance; for SIFPclamp) this definition is made in terms of absolute glucose clearance (the insulin-induced decrement in HGO is not included). This distinction results in a small but significant difference between SI and Spfciamp) in a given individual (see Discussion). Also, it is important to note that although glucose clearance itself decreases significantly at physiological hyperglycemia (ref. 24 and 
